Jazz Pharmaceuticals strives through strategic growth amid competitive pressures and financial recalibration.
Overview
Jazz Pharmaceuticals is a global biopharmaceutical company that focuses on diseases with significant unmet needs in neuroscience and oncology. The company's diverse product portfolio generated $4.1 billion in revenue in 2024, marking a 6% increase from the previous year. Key product areas, including sleep medicine and oncology, each contribute significantly to this revenue, demonstrating their strategic importance and highlighting the company’s ability to provide critical therapeutic solutions across multiple areas.